Coronavirus Disease 2019-associated Pulmonary Aspergillosis: Do We Have the CAPAcity to Improve Outcomes?
Clin Infect Dis
.
2022 Jan 7;74(1):92-94.
doi: 10.1093/cid/ciab259.
Author
John W Baddley
1
Affiliation
1
University of Maryland School of Medicine and Baltimore VA Medical Center, Baltimore, Maryland, USA.
PMID:
33754152
PMCID:
PMC8083609
DOI:
10.1093/cid/ciab259
No abstract available
Keywords:
Aspergillus; Aspergillosis; CAPA; COVID-19.
Publication types
Editorial
Comment
MeSH terms
COVID-19*
Humans
Invasive Pulmonary Aspergillosis*
Pulmonary Aspergillosis*
SARS-CoV-2
Grants and funding
Pfizer, Eli Lilly, R-Pharm, and Viela Bio